Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Gainesville, Florida 32608


Purpose:

The purpose of this study is to identify the highest tolerated doses in drugs used to treat aggressive leukemia, lymphoma or multiple myeloma not responding to standard chemotherapy treatment. The drugs being used in this study include drugs frequently used in treating such diseases (mitoxantrone and etoposide) as well as a newer drug that has also been shown to be effective (topotecan).


Study summary:

The purpose of this study is to identify the highest tolerated doses in drugs used to treat aggressive leukemia, lymphoma or multiple myeloma not responding to standard chemotherapy treatment. The drugs being used in this study include drugs frequently used in treating such diseases (mitoxantrone and etoposide) as well as a newer drug that has also been shown to be effective (topotecan).


Criteria:

Inclusion Criteria: Patients in the following disease categories will be considered eligible for this study: - Any acute leukemia beyond an initial attempt to induce a remission or after relapse - Chronic Myelogenous Leukemia in Blast Phase - Refractory Multiple Myeloma - Refractory non-Hodgkin's and Hodgkin's Lymphoma - Patients must be more than 14 days beyond prior myelotoxic chemotherapy - Several other eligibility criteria apply. Exclusion Criteria: - None


NCT ID:

NCT00100477


Primary Contact:

Principal Investigator
Mark Mainwaring
North Florida/South Georgia Veterans Health System


Backup Contact:

N/A


Location Contact:

Gainesville, Florida 32608
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.